Comparison of Ticagrelor and Clopidogrel in Elective Coronary Stenting: A Double Blind Randomized Clinical Trial.
Mohammadjavad Mehdizadeh PariziReza Golchin VafaAmin AhmadiReza HeydarzadeMehrdad SadeghiAmin KhademolhossseiniFarhang AmiriSoroush Khoshnood MansorkhaniAli TavanNazanin HosseiniMohammad MontaseriSeyed Ali HosseiniJavad KojuriPublished in: Journal of interventional cardiology (2023)
New-onset dyspnea was recorded more frequently with ticagrelor than clopidogrel, yet fewer MACEs occurred with ticagrelor (ClinicalTrials.gov number: NCT05858918).